Evidence-based immune-modulating nutritional therapy in critically ill and injured patients

J. Con, B. Joseph, N. Kulvatunyou, A. Tang, Terence OKeeffe, J. L. Wynne, R. S. Friese, P. Rhee, R. Latifi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Immunonutrition, both immune-enhancing (IE) and immune-modulating (IM), has become an important therapeutic option in the care of critically ill and injured patients. Methods: Review of current literature and evidence on the use of immunonutrition, in particular use of immune enhancing and immune modulating nutrition support in critically ill and injured patients. Results: We have gained much knowledge on the changes and on the mechanism of action of key nutrients and their substrates during critical illness and severe injuries, especially in acute respiratory distress syndrome (ARDS), sepsis, and septic shock; accordingly, the use of such nutrients and substrates has increased dramatically and has become Level I evidence (per the U.S. Preventive Services Task Force). Conclusions: There has been a significant paradigm shift with regard to selecting the appropriate nutritional strategy for critically ill and injured patients. Doing so for a particular patient and particular disease is no longer regarded as a supportive measure. Rather, it is regarded as direct nutritional therapy, based on molecular changes and on the biology of key nutrients induced by the disease process.

Original languageEnglish (US)
Pages (from-to)13-18
Number of pages6
JournalEuropean Surgery - Acta Chirurgica Austriaca
Volume43
Issue number1
DOIs
StatePublished - Feb 1 2011
Externally publishedYes

Fingerprint

Critical Illness
Food
Adult Respiratory Distress Syndrome
Advisory Committees
Therapeutics
Septic Shock
Sepsis
Wounds and Injuries

Keywords

  • γ-linolenic acid (GLA)
  • Acute respiratory distress syndrome (ARDS)
  • Antioxidants
  • Arginine
  • Branched-chain amino acids (BCAAs)
  • Eicosapentaenoic acid (EPA)
  • Glutamine
  • Immune-enhancing nutrition
  • Immune-modulating nutrition
  • Immunomitrition
  • Nucleotides
  • Omega-3 fatty acids
  • Selenium

ASJC Scopus subject areas

  • Surgery

Cite this

Evidence-based immune-modulating nutritional therapy in critically ill and injured patients. / Con, J.; Joseph, B.; Kulvatunyou, N.; Tang, A.; OKeeffe, Terence; Wynne, J. L.; Friese, R. S.; Rhee, P.; Latifi, R.

In: European Surgery - Acta Chirurgica Austriaca, Vol. 43, No. 1, 01.02.2011, p. 13-18.

Research output: Contribution to journalArticle

Con, J, Joseph, B, Kulvatunyou, N, Tang, A, OKeeffe, T, Wynne, JL, Friese, RS, Rhee, P & Latifi, R 2011, 'Evidence-based immune-modulating nutritional therapy in critically ill and injured patients', European Surgery - Acta Chirurgica Austriaca, vol. 43, no. 1, pp. 13-18. https://doi.org/10.1007/s10353-011-0588-8
Con, J. ; Joseph, B. ; Kulvatunyou, N. ; Tang, A. ; OKeeffe, Terence ; Wynne, J. L. ; Friese, R. S. ; Rhee, P. ; Latifi, R. / Evidence-based immune-modulating nutritional therapy in critically ill and injured patients. In: European Surgery - Acta Chirurgica Austriaca. 2011 ; Vol. 43, No. 1. pp. 13-18.
@article{6e4a61b0938f47dfa6cdfc9b34475668,
title = "Evidence-based immune-modulating nutritional therapy in critically ill and injured patients",
abstract = "Background: Immunonutrition, both immune-enhancing (IE) and immune-modulating (IM), has become an important therapeutic option in the care of critically ill and injured patients. Methods: Review of current literature and evidence on the use of immunonutrition, in particular use of immune enhancing and immune modulating nutrition support in critically ill and injured patients. Results: We have gained much knowledge on the changes and on the mechanism of action of key nutrients and their substrates during critical illness and severe injuries, especially in acute respiratory distress syndrome (ARDS), sepsis, and septic shock; accordingly, the use of such nutrients and substrates has increased dramatically and has become Level I evidence (per the U.S. Preventive Services Task Force). Conclusions: There has been a significant paradigm shift with regard to selecting the appropriate nutritional strategy for critically ill and injured patients. Doing so for a particular patient and particular disease is no longer regarded as a supportive measure. Rather, it is regarded as direct nutritional therapy, based on molecular changes and on the biology of key nutrients induced by the disease process.",
keywords = "γ-linolenic acid (GLA), Acute respiratory distress syndrome (ARDS), Antioxidants, Arginine, Branched-chain amino acids (BCAAs), Eicosapentaenoic acid (EPA), Glutamine, Immune-enhancing nutrition, Immune-modulating nutrition, Immunomitrition, Nucleotides, Omega-3 fatty acids, Selenium",
author = "J. Con and B. Joseph and N. Kulvatunyou and A. Tang and Terence OKeeffe and Wynne, {J. L.} and Friese, {R. S.} and P. Rhee and R. Latifi",
year = "2011",
month = "2",
day = "1",
doi = "10.1007/s10353-011-0588-8",
language = "English (US)",
volume = "43",
pages = "13--18",
journal = "European Surgery - Acta Chirurgica Austriaca",
issn = "0001-544X",
publisher = "Springer Wien",
number = "1",

}

TY - JOUR

T1 - Evidence-based immune-modulating nutritional therapy in critically ill and injured patients

AU - Con, J.

AU - Joseph, B.

AU - Kulvatunyou, N.

AU - Tang, A.

AU - OKeeffe, Terence

AU - Wynne, J. L.

AU - Friese, R. S.

AU - Rhee, P.

AU - Latifi, R.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Background: Immunonutrition, both immune-enhancing (IE) and immune-modulating (IM), has become an important therapeutic option in the care of critically ill and injured patients. Methods: Review of current literature and evidence on the use of immunonutrition, in particular use of immune enhancing and immune modulating nutrition support in critically ill and injured patients. Results: We have gained much knowledge on the changes and on the mechanism of action of key nutrients and their substrates during critical illness and severe injuries, especially in acute respiratory distress syndrome (ARDS), sepsis, and septic shock; accordingly, the use of such nutrients and substrates has increased dramatically and has become Level I evidence (per the U.S. Preventive Services Task Force). Conclusions: There has been a significant paradigm shift with regard to selecting the appropriate nutritional strategy for critically ill and injured patients. Doing so for a particular patient and particular disease is no longer regarded as a supportive measure. Rather, it is regarded as direct nutritional therapy, based on molecular changes and on the biology of key nutrients induced by the disease process.

AB - Background: Immunonutrition, both immune-enhancing (IE) and immune-modulating (IM), has become an important therapeutic option in the care of critically ill and injured patients. Methods: Review of current literature and evidence on the use of immunonutrition, in particular use of immune enhancing and immune modulating nutrition support in critically ill and injured patients. Results: We have gained much knowledge on the changes and on the mechanism of action of key nutrients and their substrates during critical illness and severe injuries, especially in acute respiratory distress syndrome (ARDS), sepsis, and septic shock; accordingly, the use of such nutrients and substrates has increased dramatically and has become Level I evidence (per the U.S. Preventive Services Task Force). Conclusions: There has been a significant paradigm shift with regard to selecting the appropriate nutritional strategy for critically ill and injured patients. Doing so for a particular patient and particular disease is no longer regarded as a supportive measure. Rather, it is regarded as direct nutritional therapy, based on molecular changes and on the biology of key nutrients induced by the disease process.

KW - γ-linolenic acid (GLA)

KW - Acute respiratory distress syndrome (ARDS)

KW - Antioxidants

KW - Arginine

KW - Branched-chain amino acids (BCAAs)

KW - Eicosapentaenoic acid (EPA)

KW - Glutamine

KW - Immune-enhancing nutrition

KW - Immune-modulating nutrition

KW - Immunomitrition

KW - Nucleotides

KW - Omega-3 fatty acids

KW - Selenium

UR - http://www.scopus.com/inward/record.url?scp=79958119321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958119321&partnerID=8YFLogxK

U2 - 10.1007/s10353-011-0588-8

DO - 10.1007/s10353-011-0588-8

M3 - Article

AN - SCOPUS:79958119321

VL - 43

SP - 13

EP - 18

JO - European Surgery - Acta Chirurgica Austriaca

JF - European Surgery - Acta Chirurgica Austriaca

SN - 0001-544X

IS - 1

ER -